Taken together, these data strongly suggest that HMGB1 release following treatment of tumor cells with a variety of cytotoxic agents is a wide-spread phenomenon regardless of tumor cell type or tumor cell killing approach. This evidence concerns the gene HMGB1 and neoplasm.